Sequana Medical NV: Results from Sequana Medical's RED DESERT alfapump DSR study selected for presentation at the Heart Failure 2021 Online Congress : vimarsana.com
Ghent, BELGIUM - 9 June 2021 - Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical"), an innovator in the treatment of diuretic-resistant fluid overload in liver disease